Topic:
Patient Recruitment
Latest Headlines
Latest Headlines
Microsoft developing database to diversify clinical trials
Microsoft is applying its database know-how to the problem of the lack of minority participation in clinical trials. The tech giant is turning data gathered by the National Minority Quality Forum into a searchable national archive to support the diversification of trials.
Covance teams with U.K.'s NHS Trust on Phase I trials
Covance has formed an alliance with Royal Liverpool and Broadgreen University Hospitals NHS Trust to conduct early clinical trials for biotech and pharma clients.
Quintiles recruiting for AstraZeneca's novel depression drug
AstraZeneca is reaching out to Quintiles as it gathers data on AZD6765, part of a newfangled class of depression drugs that promises to beat what's on the market.
CROs lack oversight, report says; ACRO cries foul
The majority of Big Pharma companies use CROs to conduct clinical trials in the developing world, but very few could provide evidence that they'd ever disciplined contractors that ran afoul of ethics codes, possibly putting participants at risk, according to a study by the Access to Medicine Foundation.
CRA buys Radiant Research to increase trial capacity
CRA Holdings, the parent company of Clinical Research Advantage, has agreed to buy Radiant Research, expanding its number of trial sites and study capabilities.
Outsourcers: Patient access more importance than price
Access to patients trumps cost among pharma outsourcers shopping for CROs, according to a new poll from ISR Reports.
Parexel targeting small, mid-size biopharmas
Parexel International is reaching out to small and mid-sized biopharma companies, launching a wing of its business that specializes in suiting the needs of companies outside the big time.
10 Reasons Why Biotech Needs Big Data
We've rounded up 10 ways huge stockpiles of data and large-scale data analysis are changing the biotech game.
10 Reasons Why Biotech Needs Big Data
We've rounded up 10 ways huge stockpiles of data and large-scale data analysis are changing the biotech game.
Study: Low-income patients less likely to join cancer trials
Patients with incomes less than $50,000 a year are less likely to participate in clinical trials, a new study finds, raising concerns about accessibility and education.
